All In Biotech

Drug Trial Radar · NCT00783692

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease

A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicenter Study of the Induction and Maintenance of Clinical Response and Remission by Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease

Last checked: Nov 20, 2026Latest source record: Jul 21, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,116 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,116

Actual

Start

Dec 2008

Primary completion

Mar 2012

Study completion May 2012

Sponsor

Lead sponsor
Millennium Pharmaceuticals, Inc.Takeda (TAK)
Sponsor type
Industry
First posted
Nov 3, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Factorial
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study was to determine the effect of vedolizumab induction treatment on clinical response and remission at 6 weeks and to determine the effect of vedolizumab maintenance treatment on clinical remission at 52 weeks.

Conditions

  • Crohn's Disease

Interventions

  • vedolizumabDrug

    Vedolizumab for intravenous infusion

  • PlaceboOther

    Placebo intravenous infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Induction Phase: Percentage of Participants Achieving Clinical Remission at Week 6Time frame: Week 6
  2. Induction Phase: Percentage of Participants With Enhanced Clinical Response at Week 6Time frame: Baseline and Week 6
  3. Maintenance Phase: Percentage of Participants Achieving Clinical Remission at Week 52Time frame: Week 52

Locations

114 sites in 3 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Apex Clinical Trials

    Birmingham, Alabama

  • Gastrointestinal Bioscience

    Los Angeles, California

  • Paramount Medical Specialty

    Montebello, California

  • Capital Gastroenterology Consultants Medical Group

    Sacramento, California

  • Clinical Applications Laboratories Inc.

    San Diego, California

  • Desta Digestive Disease Medical Center

    San Diego, California

  • University of Colorado Health Sciences Center

    Aurora, Colorado

  • Rocky Mountain Clinical Research, LLC

    Golden, Colorado

  • Gastroenterology of the Rockies

    Lafayette, Colorado

  • Arapahoe Gastroenterology Associates P.C.

    Littleton, Colorado

  • South Denver Gastroenterology

    Lone Tree, Colorado

  • Lynn Institute of Pueblo

    Pueblo, Colorado

  • Connecticut Gastroenterology Institute

    Bristol, Connecticut

  • Gastroenterology Center of Connecticut, P.C.

    Hamden, Connecticut

  • University of Florida

    Gainesville, Florida

  • University of Florida, Jacksonville

    Jacksonville, Florida

  • East Coast Institute for Research

    Jacksonville, Florida

  • Borland-Groover Clinic

    Jacksonville, Florida

  • Center for Advanced Gastroenterology

    Maitland, Florida

  • Osler Clinical Research

    Melbourne, Florida

  • University of Miami Miller School of Medicine

    Miami, Florida

  • United Medical Research Institute

    New Smyrna Beach, Florida

  • Compass Research LLC

    Orlando, Florida

  • Internal Medicine Specialists

    Orlando, Florida

  • University of South Florida

    Tampa, Florida

  • West Wind'r Research & Development, LLC

    Tampa, Florida

  • Shafran Gastroenterology Center

    Winter Park, Florida

  • Atlanta Gastroenterology Associates

    Atlanta, Georgia

  • Southeast Regional Research Group

    Columbus, Georgia

  • Atlanta Center for Gastroenterology, P.C.

    Decatur, Georgia

  • Gastroenterology Associates of Central Georgia

    Macon, Georgia

  • Digestive Research Associates

    Newnan, Georgia

  • St. Joseph's/Candler Health System

    Savannah, Georgia

  • DLW Research System

    Snellville, Georgia

  • Rush University Medical Center

    Chicago, Illinois

  • University of Chicago Medical Center

    Chicago, Illinois

  • Carle Clinic Association P.C.

    Urbana, Illinois

  • Indianapolis Gastroenterology & Hepatology, Inc.- ARC

    Indianapolis, Indiana

  • Digestive & Liver Consultants

    Clive, Iowa

Showing 40 of 114 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.